Our Unique Innovative Advantages
  • Solid innovative capability

    Solid innovative capability

    Solid scientific foundation on tumor biology

    Vigorous anti-tumor targets spectrum

    Biomarkers-guided R&D

  • Robust & well balanced pipeline

    Robust & well balanced pipeline

    11 compounds, among which 4 in phase III & 1 in pivotal phase II

    Validated targets for late stage compounds

    Multiple best-in-class potential compounds

  • Outstanding top talents

    Outstanding top talents

    Experienced in successful product approval & launch

    Covering entire oncology R&D value chain

    Close collaboration of Industry-University-Research-Hospital


HaiHe Biopharma focuses on discovery, development and commercialization of innovative anti-tumor drugs. Guided by our mission, “Inclusive and open to diversity, innovation oriented to win together and benefit the mankind”, HaiHe Biopharma insists on the way of independent innovation and pursues for global development of Chinese original innovative drugs. There are 7 compounds in clinical and 3 compounds in preclinical studies.


Address: No. 421 Newton Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai

@2019 Copyright Shanghai HaiHe Pharmaceutical Co.,Ltd All Rights Reserved.

All Rights Reserved. 沪ICP备12016151号 


HaiHe Biopharma

on Wechat